Make your fb Status With a Fake Name.

1.Go to this Website from here.
2.Then Click on Connect button after then allow the apps to connect to your facebook account.

3.Then the wall machine box appear. This box is customizable edit names and Photos.

4.After the all steps are completed then click on save button.

5.Then open your save file in new tab and take a photo by print screen.

Read More

EID Collection of River Stone with Prices Special Sale

Read More

GSM Secret Codes

Type *#61# and press call - Check redirection status.Cancel all redirections:

##002# *43# to activate call waiting, to deactivate #43#.

If your phone doesn't have incoming call barring and outgoing call barring, you can try this. For outgoing call barring dial *33*barcode*# and pres OK.

To deactivate it dial #33#barcode*#. On any phone on any network type in **43# to enable conference calls. You can make up to 7 calls at onceIf you need to block SMS reception (if you are spammed by someone) just press this code: *35*xxxx*16# xxxx is your Call Barring code (default is 0000). To remove this barring type: #35*xxxx# If you want to hide/show your phone number when calling, put one of these codes below in front of the number that you are going to call.(*#30# / *#31# or *31# / #31# ) Works on some networks.Typing *0# or *nm# on the beginning of a txt message gives you detailed delivery report on some networks.. But turn off reports in message settings before.When the sim card-pin blocked type **042*pin2 old*newpin2*newpin2*

Read More

Use Free Zong Internet In Pakistan

hey........!!! frends i am telling about how can use free internet in your mobile with ZONG connection
its 2 simple Step:



STEP: (1)  => Go Write Msg Option  type your: Mobile Company Name, Mobile Model, Internet

And send Msg 131
 
=>>> PlzZ save your setting
with code 1234

STEP: (2)  
=> And than Go Internet setting profile
Edit: APN
Change your APN setting; 

==>> Type this One
 
APN: Wapgw: 10.81.6.33
Use Free Internet & enjoy....

Read More

Paste blank Status on Facebook

Today i will show you how to publish single line or multiple line blank status on facebook. You can also use this method in facebook comments. So lets get started.

   For single line Blank Status

• Copy below codes into your status
  

• @[0:0: ]

• Note:- the text is like @[0:0:space]
• Dont write space where i have writen space rather press spacebar.
  
  For MultiLine Blank Status :
  
  
  • Paste as shown below in your staus.

  • @[0:0: ]
    @[0:0: ]
    @[0:0: ]
    @[0:0: ]
    @[0:0: ]
    @[0:0: ]

  
  Done ! subscribe below for such great posts.  

Read More

Feasibility of using mycoherbicides to control illicit drug crops is uncertain

ScienceDaily (Nov. 30, 2011) — The effectiveness of using specific fungi as mycoherbicides to combat illicit drug crops remains questionable due to the lack of quality, in-depth research, says a new report from the National Research Council. Questions about the degree of control that could be achieved with such mycoherbicides, as well as uncertainties about their potential effects on nontarget plants, microorganisms, animals, humans, and the environment must be addressed before considering deployment. The report states that additional research is needed to assess the safety and effectiveness of proposed strains of mycoherbicides.

Mycoherbicides, created from plant pathogenic fungi, have been proposed as one tool to eradicate illicit drug crops. Congress requested an independent examination of the scientific issues associated with the feasibility of developing and implementing naturally occurring strains of these fungi to control the illicit cultivation of cannabis, coca, and opium poppy crops.

As an initial step, the report recommends research to study several candidate strains of each fungus in order to identify the most efficacious under a broad array of environmental conditions. The resulting information would guide decisions regarding product formulation, the appropriate delivery method, and the scale required to generate enough mycoherbicide product to achieve significant control. However, conducting the research does not guarantee that a feasible mycoherbicide product will result. Furthermore, countermeasures can be developed against mycoherbicides, and there are unavoidable risks from releasing substantial numbers of living organisms into an ecosystem.

Multiple regulatory requirements would also have to be met before a mycoherbicide could be deployed. Additional regulations and agreements might also be needed before these tools could be used internationally, as approval to conduct tests in countries where mycoherbicides might be used has been difficult or impossible to obtain in the past.

The study was sponsored by the Office of National Drug Control Policy. The National Academy of Sciences, National Academy of Engineering, Institute of Medicine, and National Research Council make up the National Academies. They are independent, nonprofit institutions that provide science, technology, and health policy advice under an 1863 congressional charter. Panel members, who serve pro bono as volunteers, are chosen by the Academies for each study based on their expertise and experience and must satisfy the Academies' conflict-of-interest standards. The resulting consensus reports undergo external peer review before completion.

Report.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by National Academy of Sciences.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Note: If no author is given, the source is cited instead.

Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.

View the original article here

Read More

Researchers develop blood test to detect membranous nephropathy

ScienceDaily (Nov. 30, 2011) — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) has led to the development of a test that can help diagnose membranous nephropathy in its early stages. The test, which is currently only offered in the research setting and is awaiting commercial development, could have significant implications in the diagnosis and treatment of the disease. Currently, the only way to diagnose the disease is through a biopsy.

The pioneering work is being led by Laurence Beck, MD, PhD, assistant professor of medicine at BUSM and a nephrologist at BMC, and David Salant, MD, professor of medicine at BUSM and chief of the renal section at BMC.

Over the past four years, the Halpin Foundation has contributed more than $350,000 to Beck to investigate the genetics and molecular mechanisms behind membranous nephropathy. Most recently, Beck was awarded a $50,000 grant from the Foundation to further his efforts.

Membranous nephropathy is an autoimmune disease caused by the immune system attacking the kidneys, resulting in the thickening and dysfunction of the kidney's filters, called glomeruli. When antibodies attack the glomeruli, large amounts of protein in the urine are released. In 2009, Beck and Salant identified that the antibodies were binding to a protein in the glomeruli. They determined that the target was a protein called PLA2R, or phospholipase A2 receptor, and these findings were published in the New England Journal of Medicine.

"For the first time, a specific biomarker has been identified for this relatively common kidney disease," said Beck, who is part of an international collaboration that has demonstrated that these antibodies are present in patients from many different ethnicities.

With the antigen protein identified, Beck and Salant have developed a blood test to detect and measure the amount of the specific antibodies in a sample.

Approximately one third of patients with membranous nephropathy eventually develop kidney failure, requiring dialysis or a kidney transplant. According to the University of North Carolina's Kidney Center, the disease affects people over the age of 40, is rare in children and affects more men than women. This disease is treated by high powered chemotherapy, and if successful, the antibodies go away.

"Being able to detect the presence of these antibodies using a blood test has tremendous implications about who is treated, and for how long, with the often toxic immunosuppressive drugs," said Beck.

Beck continues his research focus on the treatment of the disease by targeting the antibodies and stopping them from attacking the glomeruli.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by Boston University Medical Center.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

View the original article here

Read More